Cancer research is the priority at the Princess Margaret (PM) Cancer Centre, one of the University Health Network's five research institutes.
Researchers here employ state-of-the-art tools in genomics, proteomics, structural biology, molecular biology, biophysics and the behavioural sciences.
With these tools they analyze cancerous cells at the molecular level; test gene and cellular therapies for cancer and other diseases; develop new technologies for diagnosing and treating cancer; determine the effects of diet and behaviour on cancer risks; and develop and test informatics tools for the large-scale analysis of patient populations.
Download a one-page fact sheet that highlights PM research advancements and statistics.
The Campbell Family Cancer Research Institute
The newest addition to the PM Cancer Centre, this institute will accelerate the pace of breakthrough cancer research, facilitating the translation of cancer discoveries into new life-saving therapies and more personalized cancer treatments for each patient.
The Campbell Family Institute for Breast Cancer Research
Recognizing the need to combat the most common cancer in Canadian women, this institute focuses on developing the next generation of treatments for breast cancer patients. Led by internationally recognized scientists Drs. Tak Mak and Pamela Ohashi, The Campbell Family Institute
for Breast Cancer Research
joins together basic, translational and clinical research and will focus on developing new drugs and therapies that are more effective, less toxic and can increase a patient’s quality and length of life.
*Metrics for each institute were calculated by considering data on all researchers, which include CCRU or Clinical Researchers as applicable. Please note that Clinical Researchers and CCRU investigators are not formally appointed at the research institutes and are therefore not subject to the research institutes' scientific and performance reviews.